Kiel Institute in the News
Study Finds More Than a Quarter of Adults Worldwide Could Benefit from GLP-1 Medications for Weight Loss (Jan 8, 2026)
Mass General Brigham, 14 (2): 105 - 108
The worldwide prevalence of obesity has more than doubled in the last three decades, bringing with it an increase in weight-related diseases like diabetes, cardiovascular disease, and cancers. This public health crisis strains global healthcare systems and economies, but a new study co-led by investigators from Mass General Brigham could inform strategic programs to make GLP-1 medications part of the solution.
